Literature DB >> 24325576

Preparation, optimization and characterization of bovine lactoferrin-loaded liposomes and solid lipid particles modified by hydrophilic polymers using factorial design.

Xudong Yao1, Craig Bunt, Jillian Cornish, Siew-Young Quek, Jingyuan Wen.   

Abstract

Bioadhesive liposomes and solid lipid particles (SLPs) modified by pectin and chitosan for oral administration of bovine lactoferrin (bLf) were prepared using a 2(4) full-factorial design to identify the key formulation variables influencing particle size and drug entrapment efficiency (EE). Netlike structures of the polymer-particle mixture consisting of a polymeric network in which multiple particles were imbedded were observed by scanning electron microscopy (SEM). Chemical stability of bLf after encapsulation into pectin- and chitosan-modified liposomes and SLPs was confirmed by Fourier transform infrared spectra (FTIR). Bovine lactoferrin was located within phospholipid bilayer, whereas in SLPs bLf was within the matrix. The crystalline nature of bLf after encapsulation was investigated by differential scanning calorimetry (DSC) of drug-loaded particles, indicating amorphous dispersion of bLf in the polymer-lipid matrix of pectin- and chitosan-modified liposomes and SLPs. In vivo pharmacokinetic investigation of bLf in pectin- and chitosan-modified liposomes and SLPs showed prolonged mean residence time (MRT) of bLf in rat blood and increased the relative bioavailability (Fbio %) by 1.95- to 2.69-fold compared with free bLf. The developed carrier systems are considered to be promising vehicles for oral delivery.
© 2013 John Wiley & Sons A/S.

Entities:  

Keywords:  bovine lactoferrin; hydrophilic polymer; particulate delivery system; pharmacokinetic

Mesh:

Substances:

Year:  2014        PMID: 24325576     DOI: 10.1111/cbdd.12269

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  1 in total

1.  Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells.

Authors:  Josimar O Eloy; Raquel Petrilli; Robert W Brueggemeier; Juliana Maldonado Marchetti; Robert J Lee
Journal:  Anticancer Agents Med Chem       Date:  2017       Impact factor: 2.505

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.